drugset / Trial / NCT04738097

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

NCT04738097

Phase 3 Completed 90 enrolled Mazandaran University of Medical Sciences
RandomizedParallel-groupSingle-blindPrevention

Summary

This is a randomized, controlled, active comparator arm, outcome assessor blind, parallel group design on 90 patient with diagnosis of ischemic stroke admitted in Bou-Ali Sina Hospital, Sari,Iran.The aim of study is assess the efficacy of ticagrelor plus aspirin in reduce of minor non-cardioembolic ischemic stroke or high risk TIA recurrence during first 3 months.

Timeline

Start
2021-08-08
Primary completion
2023-10-10
Completion
2023-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg
Subject Ticagrelor Small molecule 90 mg